Stella, Martina http://orcid.org/0000-0001-9794-3184
van Rooij, Rob http://orcid.org/0000-0001-8546-8283
Lam, Marnix G. E. H. http://orcid.org/0000-0002-4902-9790
de Jong, Hugo W. A. M. http://orcid.org/0000-0002-3000-8316
Braat, Arthur J. A. T. http://orcid.org/0000-0002-8824-8697
Clinical trials referenced in this document:
Documents that mention this clinical trial
Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
https://doi.org/10.1186/s13550-023-00996-1
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWA.ID.17.059.)
Article History
Received: 24 March 2023
Accepted: 8 May 2023
First Online: 15 July 2023
Declarations
:
: The HEPAR PLuS study was approved by the Medical Ethics Committee of the University Medical Center Utrecht in 2014 certifying that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent to use their personal data for research purposes was obtained from all participants.
: Written informed consent was obtained from the patients for publication of this study and accompanying images.
: MS was employed by the UMC Utrecht under a collaborative grant of the Dutch Research Council (NWO) between UMC Utrecht and Quirem Medical BV. RvR and HWAMdJ have acted as consultants for BTG/Boston Scientific. AJATB has acted as consultant for BTG/Boston Scientific and Terumo. MGEHL has acted as a consultant for BTG/Boston Scientific and Terumo and receives research support from BTG/Boston Scientific and Quirem Medical BV. The department of Radiology and Nuclear Medicine of the UMC Utrecht receives royalties from Quirem Medical BV. No other potential conflicts of interest relevant to this article exist.